Search

Twist Bioscience Corp

Cerrado

SectorSanidad

136.16 1.68

Resumen

Variación precio

24h

Actual

Mínimo

121.26

Máximo

136.6

Métricas clave

By Trading Economics

Ingresos

9M

-35M

Ventas

7.7M

118M

BPA

-0.56

Margen de beneficios

-29.61

Empleados

979

EBITDA

9.8M

-28M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-14.71% downside

Dividendos

By Acuity

Próximas Ganancias

13 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1.5B

7.8B

Apertura anterior

134.48

Cierre anterior

136.16

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

124 / 339 Clasificación en Healthcare

Twist Bioscience Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 sept 2026, 20:08 UTC

Social Media

Twist Bioscience shares are higher after being identified for bullish potential, supported by a MACD pinch technical indicator. The stock advanced despite earlier session dips.

10 sept 2026, 23:01 UTC

Twist Bioscience Corp shares are trading higher in after-market hours. No specific news was identified to explain the movement.

9 sept 2026, 20:07 UTC

News
Correlated Moves

Twist Bioscience shares are lower as BWS Financial initiates coverage with a Sell rating, contrasting UBS's Neutral rating and higher price target of $144.00.

8 sept 2026, 20:07 UTC

News
Social Media

Twist Bioscience Corp shares are higher, driven by increased recognition of AI applications in healthcare and a "Moderate Buy" consensus rating from brokerages.

3 sept 2026, 19:36 UTC

News

Twist Bioscience reported $118.4 million in Q3 revenue and raised its guidance, yet shares are lower, continuing a five-session decline.

2 sept 2026, 23:06 UTC

Twist Bioscience Corp. shares are lower in after-market hours, extending a trend of five consecutive daily declines. Earlier, the stock briefly rose before falling again.

1 sept 2026, 19:56 UTC

Correlated Moves

Twist Bioscience Corp shares are lower amid broader market pressures and rising Treasury yields. The Russell 2000 Index also declined during Tuesday's session.

31 ago 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, following no specific news. The stock remains above its 20-day moving average.

28 ago 2026, 22:51 UTC

Twist Bioscience shares are higher in after-market trading. Rising Treasury yields may be influencing investor sentiment in the biotechnology sector.

27 ago 2026, 23:02 UTC

Twist Bioscience shares are higher in after-market hours, recovering from earlier losses. Jobless claims data suggests strength in the labor market.

26 ago 2026, 19:36 UTC

Twist Bioscience Corp shares are trading higher today, maintaining a position near the upper end of their one-month range. No specific news has been identified.

25 ago 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market hours, rebounding from a post-close low amid broader market support from falling crude oil prices and treasury yields.

24 ago 2026, 23:51 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining gains from earlier in the session and staying above key moving averages.

21 ago 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, despite remaining well above their 20-day moving average and last month's price levels.

20 ago 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading. Broader market pressures, including rising crude oil prices and geopolitical tensions, may be influencing sentiment.

19 ago 2026, 23:06 UTC

News
Correlated Moves

Twist Bioscience Corp shares are lower in after-market hours following a critical short report from Scorpion Capital questioning the company's AI-driven protein design strategy.

18 ago 2026, 23:21 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining an upward trend and positioned above its 20-day moving average.

17 ago 2026, 22:36 UTC

Twist Bioscience Corp shares are slightly higher in after-market hours, maintaining strong performance above their 20-day moving average despite earlier declines.

14 ago 2026, 19:06 UTC

Twist Bioscience shares are lower today, continuing a decline since Thursday amid broader market volatility and recent U.S. retail sales data.

13 ago 2026, 23:06 UTC

Correlated Moves

Twist Bioscience Corp shares are lower in after-market trading, influenced by broader market declines and recent macroeconomic data on jobless claims and producer prices.

12 ago 2026, 19:16 UTC

Twist Bioscience Corp is higher Wednesday, tracking broader U.S. stock gains amid strength in AI sectors following positive quarterly results from CoreWeave and Super Micro Computer.

11 ago 2026, 23:46 UTC

Correlated Moves

Twist Bioscience Corp shares declined during after-market hours, following a drop in the Russell 2000 Index amid investor caution ahead of the consumer price index report.

10 ago 2026, 20:03 UTC

News
Social Media

Twist Bioscience Corp shares are higher today, buoyed by positive social media sentiment and a notable increase in trading volume since Friday's close.

7 ago 2026, 19:51 UTC

Twist Bioscience Corp shares are higher during Friday's session, with strong market activity and unusually high volume. No specific news explains this movement.

6 ago 2026, 22:56 UTC

Twist Bioscience Corp shares are higher in after-market trading, reflecting positive momentum since Thursday's close amid broader economic data indicating labor market strength.

5 ago 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4 ago 2026, 23:01 UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3 ago 2026, 22:16 UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31 jul 2026, 19:56 UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

30 jul 2026, 10:16 UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

Comparación entre iguales

Cambio de precio

Twist Bioscience Corp previsión

Precio Objetivo

By TipRanks

-14.71% descenso

Estimación a 12 Meses

Media 108.5 USD  -14.71%

Máximo 144 USD

Mínimo 45 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Twist Bioscience Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

8

Comprar

2

Mantener

1

Vender

Sentimiento

By Acuity

124 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat